ϸ°ûÉúÎïѧ£º /~;!Ew|q
Ò»¡¢ Ãû´Ê½âÊÍ£º o^"OKHU,S0
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© ns
\I Y<Yo
2£® PCR£¨96£© I
2OQ
3£® ·ºËØ£¨ubquitin£©£¨96£© {=Jo!t;f
4£® °é·Ö×Ó£¨chapron£©£¨96£© < Mu`,Kv*
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© XSK<hr0m
6£® DG£IP3£¨96£© LA2/<:
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© _Ds,91<muQ
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© X2%(=B
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© OA\]|2 :
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© %+|sbRBb
11£® Transformation£¨92£© ?)k]Vg.
12£® TransfectionתȾ£¨92£© >!']w{G
13£® Transcytosis×ªÒÆ×÷Óã¨92£© j}
^3v #
14£® Transductionתµ¼£¨92£© F$'u`
15£® Transdetermination£¨92£© Qyx~={.C~
16£® Transdifferentiation£¨92£© d-tg^Ot#
17£® Transgenic animalת»ùÒò¶¯Î92£© A9K$:mL<2
18£® Rb£1£¨92£© n4+q7
19£® P53£¨92¡¢91£© lfC]!=2%~8
20£® C£jun£¨92£© y6[ le*T
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© }Kp<w,
22£® °ûÄÚÌ壨99£© rrj.]^E_~
23£® Cyclin dependent kinase inhibitor(CDKI)(99) <Y1Plc
24£® G£protein£¨91£© ty[p5%L1
25£® Restriction point£¨91£© 0wV9Trp
26£® Antipost£¨91£© wik<#ke
27£® Capping£¨91£© ~@xPoD&
28£® TATAbox£¨91£© AgSAjBP
29£® cDNA library£¨90£© CyYr5 D
z
30£® Aritotic apparatus£¨90£© v3M$UiN,:
31£® ¿çĤÐźŠtransmembrane signal£¨90£© dz+Dk6"R
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£©
vBF9!6X .
33£® Nuclear lamina£¨90£© V|sV U
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© \6?a
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© G&1bhi52
36£® ϸ°û·Ö»¯£¨00£© ~v pIy -
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© @,k5T51m
38£® ¿Ë¡£¨00£© 5toa@#Bc%
39£® »ùÒò×飨00£© =dKjTBR S'
40£® Caspase£¨00£© O]@#53)Tz
41£® ת¼Òò×Ó£¨00£© ZM v\j|{8
42£® ÅßÌ¥¸Éϸ°û£¨01£© 5~IdWwG*w
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© gz[3 xH~
44£® DNAоƬ£¨01£© YT(Eh3ID
¶þ¡¢ ÎÊ´ðÌ⣺ t4v'X}7q]
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© ?-mOAHW0q
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© $'Mf$h
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© `{Q'iydU
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© 6Nn+7z<*&z
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© At=d//5FFP
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© /R=MX>JA;
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© `DgK$ QM
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£©
-NN=(p!<
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© !a F~5P7%
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© |> ]@w\]
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© DWKQ>X6
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© X7L:cVBg
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© KU` *LB:
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© lNg){3
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© |3,WiK='
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© T*C25l;w
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© bT2G
G
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© >iOf3I-ATt
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© 8ex;g^e
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© mXyP;k
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© Y#68_%[
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© Hm'"I!jyO
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© ye$_=KARP
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© Zhfg
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© a&b/C*R_
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© g-d{"ZXd J
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© lY
tt|J
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© 4DCh+|r
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© WC~;t4
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© ~-7/9$ay5
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© {\1bWr8!U
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© C][hH?.
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© 'M"z3j]m-,
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© "crR{OjE"
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©